Companies: 10,795·Total market cap: $144.5T
Incyte Corporation

Incyte Corporation

INCYNASDAQHealthcare● Active
$100.64
$-1.74(-1.70%)
Market Cap$20.1B
P/E Ratio
52W High$112.29
52W Low$66.74

Incyte Corporation(INCY)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · INCY · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$5.14B$4.24B$3.70B$3.39B$2.99B
Cost of Revenue$0.37B$0.31B$0.25B$0.21B$0.15B
Gross Profit$4.77B$3.93B$3.44B$3.19B$2.84B
Gross Margin %(computed)92.76%92.64%93.10%93.90%94.94%
Operating Expenses
R&D Expenses$2.05B$2.61B$1.63B$1.59B$1.46B
G&A Expenses$1.38B$1.22B$1.16B$1.00B$0.74B
Total Operating Expenses$3.43B$3.83B$2.79B$2.60B$2.25B
Operating Income$1.34B$0.10B$0.66B$0.59B$0.59B
Operating Margin %(computed)26.12%2.39%17.73%17.43%19.62%
Interest Income$0.11B$0.13B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax$1.66B$0.32B$0.83B$0.53B$0.57B
Income Tax Expense$0.38B$0.28B$0.24B$0.19B($0.38B)
Net Income$1.29B$0.03B$0.60B$0.34B$0.95B
Net Margin %(computed)25.03%0.77%16.17%10.04%31.76%
Per Share & EBITDA
EPS (Basic)$6.59$0.16$2.67$1.53$4.30
Wtd Avg Shares0.20B0.21B0.22B0.22B0.22B
EBITDA$1.76B$0.41B$0.92B$0.60B$0.63B
EBITDA Margin %(computed)34.24%9.62%24.88%17.66%21.10%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Incyte Corporation

关于Incyte Corporation(INCY)损益表

Incyte Corporation(INCY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,INCY实现营收$5.14B,毛利润$4.77B(毛利率92.76%),净利润$1.29B(净利率25.03%)。

常见问题

INCY · 4 问

Incyte Corporation(INCY)2025财年营收为$5.14B,同比up21.2%。

INCY revenueINCY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08